SCHEMBL16975129

SCHEMBL16975129

N[C@H](CC(Cc1ccc(-c2cc(Cl)ccc2F)cc1)NC(=O)c1coc(=O)[nH]1)C(=O)O

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16930699 1.00 MME (0.75) MME
SCHEMBL16930549 0.89 MME (0.72) MME
SCHEMBL16975158 0.89 MME (0.72) MME
SCHEMBL16975175 0.86 MME (0.62) MME
SCHEMBL16975174 0.86 MME (0.62) MME
SCHEMBL16930613 0.86 MME (0.62) MME
SCHEMBL16930660 0.85 MME (1.00) MME
SCHEMBL16930575 0.85 MME (1.00) MME
SCHEMBL19788075 0.82 MME (0.54) MME
SCHEMBL15472712 0.82 MME (0.54) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099678-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2016-12-07 — — EP disclosed
WO-2015116786-A1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2015-08-06 — — WO disclosed
Send feedback